TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34751757

Group type: EXPERIMENTAL
Intervention: Early surgical treatment within 24 hours after admission
Number of subjects: 70

Group type: COMPARATOR
Intervention: Delayed surgical treatment after at least 2 weeks of conservative treatment
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Early surgical treatment
Number of subjects: 70

Group type: COMPARATOR
Intervention: Delayed surgical treatment
Number of subjects: 70
Study: 35049436

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist intervention (patient counselling, patient information leaflet)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 88
Study: 34290294

Group type: EXPERIMENTAL
Intervention: FLNA
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: CLU
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: CAP1
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: FLNA and CLU combination
Number of subjects: 269

Group type: COMPARATOR
Intervention: FLNA and CLU combination (with hepatic fibrosis and non-alcoholic fatty liver as control)
Number of subjects: 269
Study: 35460915

Group type: EXPERIMENTAL
Intervention: Adaptive behavioral intervention for weight management and glycemia optimization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inpatient mechanistic phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outpatient behavioral phase
Number of subjects: 0
Study: 32727192

Group type: EXPERIMENTAL
Intervention: Gunsight closure technique
Number of subjects: 143

Group type: COMPARATOR
Intervention: Purse-string closure technique
Number of subjects: 143
Study: 34030579

Group type: EXPERIMENTAL
Intervention: Pilates exercise group (PEG)
Number of subjects: 20
Study: 35502002

Group type: EXPERIMENTAL
Intervention: Cognitive-reminiscence therapy (CRT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Wait-list (Control)
Number of subjects: 62
Study: 34590570

Group type: EXPERIMENTAL
Intervention: Senling Baizhu san (SLBZS) 100 mL, twice a day, for 12 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (SLBZS and control)
Number of subjects: 80
Study: 36220354

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 452

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 452
Study: 32419303

Group type: EXPERIMENTAL
Intervention: Exercise combined with education and manual therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Exercise combined with education
Number of subjects: 61
Study: 33973923

Group type: EXPERIMENTAL
Intervention: Bup/Nal treatment for 12 weeks
Number of subjects: 152

Group type: COMPARATOR
Intervention: Detox treatment for up to 2 weeks
Number of subjects: 152
Study: 33856337

Group type: EXPERIMENTAL
Intervention: Intensive targeted cryotherapy (crushed wetted ice in a plastic bag)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Chemical cold packs
Number of subjects: 38
Study: 33341406

Group type: EXPERIMENTAL
Intervention: 75 mg CaEDTA in Tris‐buffered saline nebulised with 250 mg tobramycin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (Tris‐buffered saline) nebulised with 250 mg tobramycin
Number of subjects: 25
Study: 32340910

Group type: EXPERIMENTAL
Intervention: Device (active mode)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Device (silent mode)
Number of subjects: 59
Study: 36014910

Group type: EXPERIMENTAL
Intervention: Conventional canola oil (CO)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High-oleic acid canola oil (HOCO)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control oil blend (CON)
Number of subjects: 31
Study: 32103280

Group type: EXPERIMENTAL
Intervention: Cue avoidance training (CAT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Behavioural effects
Number of subjects: 60
Study: 34334394

Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP) - outpatient version
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 34148150

Group type: EXPERIMENTAL
Intervention: Antisense oligonucleotides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35035537

Group type: EXPERIMENTAL
Intervention: Standard care with ‘step-up’ DMARD therapy
Number of subjects: 1

Group type: COMPARATOR
Intervention: Symptomatic therapy with NSAIDs and local corticosteroid injections
Number of subjects: 1
Study: 34023412

Group type: EXPERIMENTAL
Intervention: tDCS anode stimulation of the M1
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: tDCS anode stimulation of the SMA
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 35
Study: 32022863

Group type: EXPERIMENTAL
Intervention: Once-weekly somapacitan
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Daily GH
Number of subjects: 301

Group type: COMPARATOR
Intervention: Once-weekly placebo
Number of subjects: 301
Study: 35915506

Group type: EXPERIMENTAL
Intervention: Extended-release guanfacine (GXR)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 34802425

Group type: EXPERIMENTAL
Intervention: 6-month telephone-based wellness/support intervention
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 6-month telephone-based exercise intervention
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 450
Study: 615709281

Group type: EXPERIMENTAL
Intervention: Cannabis (54 mg) administered orally
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cannabis (6.9% THC cigarette)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Vaporized cannabis (Volcano)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: THC (3 and 10 mg/kg) administered to mice
Number of subjects: 15
Study: 35168231

Group type: EXPERIMENTAL
Intervention: Tildrakizumab 100 mg
Number of subjects: 0
Study: 33360173

Group type: COMPARATOR
Intervention: CD-LD IR
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: CD-LD ER
Number of subjects: 393
Study: 32302600

Group type: EXPERIMENTAL
Intervention: Music making activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 34569871

Group type: EXPERIMENTAL
Intervention: Picture-based medication calendar
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care without calendar
Number of subjects: 0
Study: 34180315

Group type: EXPERIMENTAL
Intervention: Donasert®
Number of subjects: 312

Group type: COMPARATOR
Intervention: Mirena®
Number of subjects: 312
Study: 32696820

Group type: EXPERIMENTAL
Intervention: Caregiver Intensive Education Program (CIEP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine guidance/education (control group)
Number of subjects: 90
Study: 36374769

Group type: COMPARATOR
Intervention: MOD-EX (Moderate-Intensity Exercise)
Number of subjects: 145

Group type: COMPARATOR
Intervention: VIG-EX (Vigorous-Intensity Exercise)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Endurance and Resistance Exercise (Acute)
Number of subjects: 145
Study: 32594702

Group type: EXPERIMENTAL
Intervention: B-flow + CDFI
Number of subjects: 67

Group type: COMPARATOR
Intervention: CDFI alone
Number of subjects: 67
Study: 33522904

Group type: EXPERIMENTAL
Intervention: Group-based Lifestyle-integrated Functional Exercise (gLiFE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Individual Lifestyle-integrated Functional Exercise (LiFE)
Number of subjects: 30
Study: 36126514

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study: 34165835

Group type: EXPERIMENTAL
Intervention: Four implants in maxillary overdentures
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Denture supported by four implants
Number of subjects: 26

Group type: COMPARATOR
Intervention: Two implants in mandibular overdentures
Number of subjects: 26
Study: 34726230

Group type: EXPERIMENTAL
Intervention: Recombinant hGH treatment (various doses)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 33279465

Group type: EXPERIMENTAL
Intervention: Guideline training for registered dietitian nutritionists (RDNs)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Standard care including nutrition intervention
Number of subjects: 102
Study: 36216216

Group type: EXPERIMENTAL
Intervention: Zein
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Casein
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (Whey)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: α-lactalbumin (ALac)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Maltodextrin carbohydrate (Carb)
Number of subjects: 13
Study: 34464358

Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (3 units) plus standard treatment
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (standard treatment alone)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Higher cumulative amount of neutralizing antibodies plus standard treatment
Number of subjects: 105
Study: 32822962

Group type: EXPERIMENTAL
Intervention: Class 3 (strong families/attachment)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Class 1 (child welfare/multi-problem families)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Class 2 (mental-health/angry-oppositional)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: All classes
Number of subjects: 216

Group type: COMPARATOR
Intervention: Classes 1, 2, and 3
Number of subjects: 216
Study: 35836148

Group type: EXPERIMENTAL
Intervention: Educational program based on the health belief model (HBM), 8 sessions long
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 280
Study: 34314402

Group type: EXPERIMENTAL
Intervention: Volar plate fixation (operative treatment)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cast immobilization (nonoperative treatment)
Number of subjects: 90
Study: 32171564

Group type: EXPERIMENTAL
Intervention: HyFlex CM (HCM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: WaveOne Gold (WOG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: OneCurve (OC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: HyFlex EDM (HEDM)
Number of subjects: 80
Study: 35641364

Group type: EXPERIMENTAL
Intervention: Resorbable magnesium scaffold (RMS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Biodegradable polymer sirolimus eluting stents (BP‐SES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Durable polymer everolimus eluting stents (DP‐EES)
Number of subjects: 30
Study: 35546018

Group type: EXPERIMENTAL
Intervention: ICS treatment
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Montelukast + Leucodif
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: ICS + Leucodif
Number of subjects: 84
Study: 33834608

Group type: EXPERIMENTAL
Intervention: 500 mg L-Cystine and 250 mg L-Glutathione
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: COMPARATOR
Intervention: 250 mg reduced L-Glutathione
Number of subjects: 124

Group type: COMPARATOR
Intervention: 500 mg L-Cystine
Number of subjects: 124
Study: 34156693

Group type: EXPERIMENTAL
Intervention: RefluG™ (galactomannan-based formulation), one sachet three times per day for 14 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RefluG™
Number of subjects: 60

Group type: COMPARATOR
Intervention: RefluG™ and Placebo
Number of subjects: 60
Study: 32086918

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Dermatophagoides Farinae
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Comparison between SLIT and Control group
Number of subjects: 72
Study: 34085881

Group type: EXPERIMENTAL
Intervention: Synbiotic supplement
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups (Synbiotic and Placebo)
Number of subjects: 88
Study: 33767795

Group type: EXPERIMENTAL
Intervention: 1% Satureja khuzestanica vaginal cream
Number of subjects: 84

Group type: COMPARATOR
Intervention: 1% clotrimazole vaginal cream
Number of subjects: 84
Study: 36242607

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBTI)
Number of subjects: 658

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 658
Study: 32529788

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 37679711

Group type: EXPERIMENTAL
Intervention: ACAT program and treatment‐as‐usual
Number of subjects: 49

Group type: COMPARATOR
Intervention: treatment‐as‐usual
Number of subjects: 49
Study: 36285551

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine plus carvedilol
Number of subjects: 300

Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 300
Study: 35435785

Group type: EXPERIMENTAL
Intervention: Digital CBTi intervention (Sleepio)
Number of subjects: 75
Study: 33789610

Group type: EXPERIMENTAL
Intervention: Amino acid infusion (200 ml IV at 100 ml/h)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (200 ml IV)
Number of subjects: 76
Study: 32867282

Group type: EXPERIMENTAL
Intervention: Ingestion of omega‐3 long chain polyunsaturated fatty acids (n‐3 LCPUFA) and multivitamin supplements
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 36239645

Group type: EXPERIMENTAL
Intervention: Thrombectomy plus medical therapy
Number of subjects: 217

Group type: COMPARATOR
Intervention: Medical therapy only (control)
Number of subjects: 217
Study: 33368782

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) treatment
Number of subjects: 121

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 121
Study: 32701239

Group type: EXPERIMENTAL
Intervention: Inverse ratio ventilation combined with positive end-expiratory pressure (PEEP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 63
Study: 36129479

Group type: EXPERIMENTAL
Intervention: Incontinence Health Belief Development Program (IHBDP) for 5 weeks
Number of subjects: 160
Study: 32852222

Group type: EXPERIMENTAL
Intervention: Postoperative labia
Number of subjects: 4513

Group type: COMPARATOR
Intervention: Preoperative labia
Number of subjects: 4513
Study: 35661491

Group type: EXPERIMENTAL
Intervention: Active cTBS (20 sessions, 2 per day for 2 weeks)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham (placebo)
Number of subjects: 59
Study: 32093625

Group type: COMPARATOR
Intervention: B + P (BONES plus Parent)
Number of subjects: 1434

Group type: COMPARATOR
Intervention: B (BONES only)
Number of subjects: 1434
Study: 32970955

Group type: EXPERIMENTAL
Intervention: Osteochondroplasty with or without labral repair
Number of subjects: 214

Group type: COMPARATOR
Intervention: Lavage with or without labral repair
Number of subjects: 214

Group type: COMPARATOR
Intervention: Lavage
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Osteochondroplasty
Number of subjects: 214
Study: 33278911

Group type: EXPERIMENTAL
Intervention: BdLEA proteins identified and analyzed; 18 BdLEAs selected for qRT-PCR analysis.
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Transcriptomic analysis of BdLEAs.
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Gene Ontology (GO) annotation of BdLEAs.
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Analysis of gene structure, evolutionary relationships, and protein motifs of BdLEAs.
Number of subjects: 67
Study: 32051083

Group type: EXPERIMENTAL
Intervention: Concerta treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Strattera treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 80
Study: 37660037

Group type: EXPERIMENTAL
Intervention: Pivmecillinam 400 mg three times daily and amoxicillin/clavulanic acid 500/125 mg three times daily for 10 days
Number of subjects: 330

Group type: COMPARATOR
Intervention: Oral ciprofloxacin 500 mg twice daily or oral trimethoprim–sulfamethoxazole 800 mg/160 mg twice daily or intravenous ertapenem 1 g once daily for 7–10 days
Number of subjects: 330
Study: 32892493

Group type: EXPERIMENTAL
Intervention: IL vitamin D3 every 4 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IL tuberculin PPD every 2 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: IL saline every 2 weeks
Number of subjects: 60
Study: 32031091

Group type: EXPERIMENTAL
Intervention: 7.5 μg of dexmedetomidine in 0.3 ml of normal saline (Group D)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 0.3 ml of normal saline alone (Group S)
Number of subjects: 70
Study: 35131893

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) via the ELLIPTA DPI (n=1081)
Number of subjects: 2236

Group type: COMPARATOR
Intervention: Usual care (n=1155)
Number of subjects: 2236
Study: 34924360

Group type: EXPERIMENTAL
Intervention: Cash transfer of $C1000
Number of subjects: 392

Group type: COMPARATOR
Intervention: Physical distancing guidelines alone
Number of subjects: 392
Study: 35550164

Group type: EXPERIMENTAL
Intervention: CRISP tool implementation
Number of subjects: 1
Study: 32212997

Group type: EXPERIMENTAL
Intervention: Laparoscopic Ureteral Extravesical Reimplantation (LUER)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Laparoscopic-Assisted Extracorporeal Ureteral Tapering Repair (EUTR)
Number of subjects: 26
Study: 35108409

Group type: EXPERIMENTAL
Intervention: Switching sides one, three, and five times during mastication
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Freestyle mastication
Number of subjects: 29
Study: 34190938

Group type: EXPERIMENTAL
Intervention: Simulation Effectiveness Tool ‐ Modified Brazilian Version
Number of subjects: 435
Study: 32772395

Group type: EXPERIMENTAL
Intervention: Single-implant (G-I)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Two-implant overdentures (G-II)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fixed 4-implant complete denture (G-III)
Number of subjects: 37
Study: 35713772

Group type: EXPERIMENTAL
Intervention: Osimertinib adjuvant therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34023577

Group type: EXPERIMENTAL
Intervention: Masimo device hemoglobin (SpHb)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Cyanomethemoglobin (HiCN)
Number of subjects: 380
Study: 35396340

Group type: EXPERIMENTAL
Intervention: CIAT-Plus
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: M-MAT
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 201
Study: 34656261

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 39
Study: 32605447

Group type: EXPERIMENTAL
Intervention: 800 mg cannabidiol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 400 mg cannabidiol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34524102

Group type: EXPERIMENTAL
Intervention: Enhanced SMS text message-based intervention (1-8 messages/month)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Enhanced SMS text message-based intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study: 33031956

Group type: EXPERIMENTAL
Intervention: Peer-driven entertainment education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-control intervention
Number of subjects: 0
Study: 35241098

Group type: EXPERIMENTAL
Intervention: CoQ10 (120 mg)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 35060336

Group type: EXPERIMENTAL
Intervention: Just-in-time planning intervention (JITPI)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Assessment only condition (control)
Number of subjects: 386
Study: 34336070

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (C‐TENS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment
Number of subjects: 60
Study: 34247263

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) 5 mg intravenous infusion once yearly for 2 years
Number of subjects: 330
Study: 32076362

Group type: EXPERIMENTAL
Intervention: Moderation-based alcohol treatment with naltrexone and Modified Behavioral Self-Control Training
Number of subjects: 178
Study: 35180190

Group type: EXPERIMENTAL
Intervention: Ketone monoester (KME; 0.5 g·kg‐1)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 14
Study: 34862881

Group type: EXPERIMENTAL
Intervention: MDD group
Number of subjects: 61

Group type: COMPARATOR
Intervention: Healthy group
Number of subjects: 61
Study: 34261858

Group type: EXPERIMENTAL
Intervention: Eflornithine (750 mg) + Sulindac (150 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Sulindac (150 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Eflornithine (750 mg)
Number of subjects: 158
Study: 33737440

Group type: EXPERIMENTAL
Intervention: self‐aligning prosthetic ankle‐foot
Number of subjects: 55

Group type: COMPARATOR
Intervention: non‐self‐aligning ankle‐foot
Number of subjects: 55
Study: 32357133

Group type: EXPERIMENTAL
Intervention: AI-BR model (machine learning model)
Number of subjects: 15603

Group type: COMPARATOR
Intervention: ACC-BR model (American College of Cardiology CathPCI bleeding risk model)
Number of subjects: 15603

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 15603
Study: 33465015

Group type: EXPERIMENTAL
Intervention: Maternal plasma ferritin at gestational week 30 (GW30)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Maternal plasma ferritin at gestational week 14 (GW14)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Maternal plasma ferritin
Number of subjects: 573
Study: 32915063

Group type: EXPERIMENTAL
Intervention: Antibacterial envelope (TYRX) adjunctive to standard-of-care infection prevention
Number of subjects: 6983

Group type: COMPARATOR
Intervention: Standard-of-care infection prevention
Number of subjects: 6983
Study: 36216962

Group type: EXPERIMENTAL
Intervention: Calcium intake >7 servings
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Vitamin D intake >7 servings
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Physical activity ≥2.5 hours
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Body fat association with lumbar spine BMD
Number of subjects: 496